Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

UK payer perspectives: Is big data the future of market access?

'UK payer perspectives: Is big data the future of market access?’ will feature Paul Sutton, Director of Outcomes and Value, Commercial UK at Quintiles and Dr Junaid Bajwa, a GP...

- PMLiVE

GSK fined $487m as Chinese probe concludes

Five former executives receive jail sentences

- PMLiVE

Cubist launches Zurich base

US antibiotic company expands into Europe

Gilead Sciences

Gilead gets EU nod for cancer drug Zydelig

Approved for patients with chronic lymphocytic leukaemia and follicular lymphoma

- PMLiVE

Bruce Peacock joins Dicerna from Ophthotech

He is appointed to its board of directors and audit committee

- PMLiVE

NHS launches MyNHS transparency site

Allows public to view performance data and shape services

- PMLiVE

Apple’s HealthKit-enabled apps delayed by bug

May take two weeks to fix new software

- PMLiVE

Publicis Groupe replaces existing management board

And Maurive Levy to stay on as CEO and chair until 2017

- PMLiVE

The M&A trend in pharma

Are pharma deals back in fashion or is big pharma in retreat and needing to reshape

Bayer symbol

Bayer to spin out material science division

German firm will focus solely on life sciences

- PMLiVE

Novo Nordisk’s Xultophy diabetes combo approved in Europe

Once-daily injection combines the firm's Tresiba and Victoza

- PMLiVE

FDA approves Lilly’s GLP-1 diabetes drug Trulicity

The once-weekly treatment is set to compete with Bydureon, Tanzeum and Victoza

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links